- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5386 - 1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
Patent holdings for IPC class A61K 31/5386
Total number of patents in this class: 701
10-year publication summary
|
52
|
42
|
59
|
47
|
47
|
71
|
89
|
74
|
71
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
23 |
| Bayer AG | 3045 |
15 |
| Genentech, Inc. | 3742 |
13 |
| Bayer Pharma AG | 1096 |
13 |
| Vertex Pharmaceuticals Incorporated | 1581 |
13 |
| Arvinas Operations, Inc. | 165 |
13 |
| Boehringer Ingelheim International GmbH | 4629 |
11 |
| Pfizer Inc. | 3322 |
11 |
| Merck Patent GmbH | 5909 |
11 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
11 |
| Merck Sharp & Dohme LLC | 3689 |
11 |
| AstraZeneca AB | 3042 |
10 |
| Bristol-myers Squibb Company | 5080 |
9 |
| Novartis AG | 11238 |
8 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
8 |
| F. Hoffmann-La Roche AG | 7958 |
7 |
| Amgen Inc. | 3779 |
7 |
| Heptares Therapeutics Limited | 225 |
7 |
| Repare Therapeutics, Inc. | 38 |
7 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 269 |
6 |
| Other owners | 487 |